AUBAGNE, France, Jan. 6, 2021 /PRNewswire/ -- Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, today announced it has entered into an agreement to acquire ...
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through ...
The "Aseptic Processing of Pharmaceutical and Biotech Products Course (Dec 11th - Dec 12th, 2025)" training has been added to ResearchAndMarkets.com's offering. This comprehensive course covers ...